Propofol β-D-glucuronide

• Description :

  Propofol β-D-glucuronide is a metabolite of Propofol sulfate and can be used for diagnosis to distinguish colorectal cancer from healthy individuals[1].

• Product Name Alternative :

  NVP-AEE 788

• UNSPSC :

  12352005

• Hazard Statement :

  H302, H315, H319, H335

• Target :

  Endogenous Metabolite

• Type :

  Reference compound

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/propofol-β-d-glucuronide.html

• Purity :

  99.55

• Solubility :

  DMF : 30 mg/mL (ultrasonic; warming) |DMSO : 100 mg/mL (ultrasonic)

• Smiles :

  CC(C1=CC=CC(C(C)C)=C1O[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)C(O)=O)C

• Molecular Formula :

  C18H26O7

• Molecular Weight :

  354.39

• Precautions :

  H302, H315, H319, H335

• References & Citations :

  [1]Tangtang, et al. Marker combination for diagnosing advanced colorectal tumor, and application thereof. Patent WO2023185709A1

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C (Powder, sealed storage, away from moisture)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [114991-26-3]